1.  Ritch R, Schlötzer-Schrehardt U. Exfoliation syndrome. Surv Ophthalmol 2001;45:265-315
  2. Schlötzer-Schrehardt U, Naumann GOH. Ocular and Systemic Pseudoexfoliation Syndrome. Am J Ophthalmol 2006;141:921-937
  3. Naumann GOH, Schlötzer-Schrehardt U, Küchle M. Ocular and Systemic Pseudoexfoliation Syndrome for the comprehensive ophthalmologist:intraocular and systemic manifestations. Ophthalmology 1998; 105:951-968
  4. Yüksel N, Karabas VL, Arslan A, Demirci A, Caglar Y. Ocular hemodynamics in pseudoexfoliation syndrome and pseudoexfoliation glaucoma. Ophthalmology 2001;108:1043-1049
  5. Harju M, Vesti E. Blood flow of the optic nerve head and peripapillary retina in exfoliation syndrome with unilateral glaucoma or ocular hypertension. Graefes Arch Clin Exp Ophthalmol 2001;239:271-277
  6. Ocakoglu O, Koyluoglu N, Karyiran A, Tamcelik N, Ozkan S. Microvascular blood flow of the optic nerve head and peripapillary retina in unilateral exfoliation syndrome. Acta Ophthalmol Scand 2004;82:49-53
  7. Netland PA, Ye H, Streeten BW,Hernandez MR. Elastosis of lamina cribrosa in pseuexfoliation syndrome with glaucoma. Ophthalmology 1995;102:878-886
  8. Purka P, Vesti E, Tomita G, Ishida K, Raitta C. Optic disc changes in normotensive persons with unilateral exfoliation syndrome: a 3-year follow-up study. Graefes Arch Clin Exp Ophthalmol 1999;237:457-462
  9. Konstas AGP, Stewart WC, Stromann GA. Clinical presentation and initial treatment patterns in patients with exfoliation glaucoma versus primary open-angle glaucoma. Ophthalmol Surg Laers 1997;28:111-117
  10. Konstas AGP, ;Mantziris DA, Stewart WC. Diurnal intraocular pressure in untreated exfoliation and primary open-angle glaucoma. Arch Ophthalmol 1997;115:182-185
  11. Lanzl IM, Merte RL, Graham AD. Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? J Glaucoma 2000; 9:214-218
  12. Teus MA, Castejon MA, Calvo MA. Intraocular pressure as a risk factor for visual field loss in pseudoexfoliative and primary open angle glaucoma. Ophthalmology 1998;105:2225-2229
  13. Ritch R. Exfoliation syndrome: the most common identificable cause of open-angle glaucoma. J Glaucoma 1996;3:176-178
  14. Konstan GP, Mylopoulos N, Karabatsas CH, et al. Diurnal intraocular pressure reduction with latanoprost 0.005% compared to timolol maleate 0.5% as monotherapy in subjects with exfoliation glaucoma. Eye 2004;18:893-899
  15. Konstas AGP, Koliakos GG, Liakos P, et al. Latanoprost therapy reduces the levels of TGF beta1 and gelatinaes in the aqueous humor of patients with exfoliative glaucoma. Exp Eye Res 2005;82:319-322
  16. Threlkeld AB, Hertzmark E, Sturm RT. Comparative study of the efficacy of argon laser trabeculoplasty for exfoliation and primary open-angle glaucoma. J Glaucoma 1996;5:311-316
  17. European Glaucoma Society. Princípios e opções terapêuticas. In: European Glaucoma Society , eds. Terminologia e protocolos para o glaucoma, 3ª edição, 2009:149
  18. Küchle M, Nguyen N, Hannappel E. The blood-aqueous barrier in eyes with pseudoexfoliation syndrome. Ophthalmic Res 1995; 27(suppl 1):136-142
  19. Nguyen NX, Küchle M, Martus P, Naumann GOH. Quantification of blood-aqueous barrier breakdown after trabeculectomy: pseudoexfoliation versus primary open-angle glaucoma. J Glaucoma 1999; 8:18
Dezembro 2012